Skip to search formSkip to main contentSkip to account menu

Vincasar PFS

Known as: PFS, Vincasar 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
OBJECTIVES The present study evaluates the prognostic value of metabolic parameters related to the primary tumor identifiedin… 
2018
2018
BackgroundThe urokinase plasminogen activator system (uPA, uPAR, PAI‑1) is upregulated in cancer and high plasma levels are… 
2016
2016
e16542 Background: A phase II trial was performed to evaluate the efficacy and safety of gefitinib and to explore epidermal… 
Review
2014
Review
2014
5556^ Background: N is an oral inhibitor of VEGFR, PDGFR, and FGFR. As reported earlier, in the AGO-OVAR12 trial, N compared to… 
2013
2013
The purpose of this prospective, nonrandomized, controlled study was to compare the regimen of continuously administering… 
2001
2001
The purpose of this study was to determine the feasibility and efficacy of multiple courses of high-dose cyclophosphamide…